First Real-World Experience Administering Etranacogene Dezaparvovec Gene Therapy for People with Hemophilia B

被引：0
|
作者：
Ryan, Matthew L. [1 ]
Miller, Andrea [2 ]
O'Hearn, Patrick [2 ]
Desai, Vidhi Parikh [3 ]
机构：
[1] Green Bay Oncol, Green Bay, WI USA
[2] Hemophilia Outreach Ctr, Green Bay, WI USA
[3] CSL Behring, King Of Prussia, PA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-190238
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Hazards of thrombolytic therapy for stroke: the real-world experience
    Hurley, J. C.
    INTERNAL MEDICINE JOURNAL, 2007, 37 (05) : 348A - 349
  • [32] APPLICATION OF GUIDELINES FOR ICD THERAPY: REAL-WORLD EXPERIENCE
    Abraham, George
    Thomas, Rebecca
    Chousou, Panagiota
    Pugh, Peter
    HEART, 2020, 106 : A56 - A57
  • [33] REAL-WORLD EXPERIENCE OF ADMINISTERING PLERIXAFOR (MOZOBIL) FOR AUTOLOGOUS PERIPHERAL BLOOD STEM CELL HARVEST
    Akazawa, M.
    Odamaki, S.
    Hori, Y.
    Nakai, S.
    Yamada, A.
    Sato, K.
    Aoki, K.
    Sato, H.
    Miyakawa, H.
    Tsukada, N.
    Ishibashi, Y.
    CYTOTHERAPY, 2019, 21 (05) : S66 - S66
  • [34] Cemiplimab as First Line Therapy in Advanced Penile Squamous Cell Carcinoma: A Real-World Experience
    Rouvinov, Keren
    Mazor, Gal
    Kozlener, Ella
    Meirovitz, Amichay
    Shrem, Noa Shani
    Abu Saleh, Omar
    Shalata, Sondos
    Yakobson, Alexander
    Shalata, Walid
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (11):
  • [35] Trevo 2000: Real-World Experience in the First 1247 Patients
    Binning, Mandy J.
    Budzik, Ronald F.
    Baxter, Blaise W.
    Bartolini, Bruno M.
    Liebeskind, David S.
    Krajina, Antonin
    English, Joey D.
    Maxwell, Christina
    Veznedaroglu, Erol
    STROKE, 2017, 48
  • [36] Real-World Experience of People with Hemophilia A Receiving Turoctocog Alfa Pegol (N8-GP) Results from a Patient Experience Survey
    Eichler, Hermann
    Nagao, Azusa
    Waller, John
    Stuber, Alexander
    PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 3001 - 3014
  • [37] Prophylactic Treatment in People with Severe Hemophilia B in the US: An Analysis of Real-World Healthcare System Costs and Clinical Outcomes
    Noone, Declan
    Pedra, Gabriel
    Asghar, Sohaib
    O'Hara, Jamie
    Sawyer, Eileen K.
    Li, Nanxin
    BLOOD, 2019, 134
  • [38] Indirect treatment comparisons of the gene therapy etranacogene dezaparvovec versus extended half-life factor IX therapies for severe or moderately severe haemophilia B
    Klamroth, Robert
    Bonner, Ashley
    Gomez, Keith
    Monahan, Paul E.
    Szafranski, Kirk
    Zhang, Xiang
    Walsh, Sarah
    Wang, Di
    Yan, Songkai
    HAEMOPHILIA, 2024, 30 (01) : 75 - 86
  • [39] Real-World Experience with Emicizumab for Hemophilia a from the Physician Perspective Based on Survey Data
    Recht, Michael
    Salehi, Hanna
    Blazos, Chris
    Lai, Sophie
    Morton, Ella
    Lee, Lucy
    Biondo, Juliana M. L.
    Lee, Janet S.
    BLOOD, 2024, 144 : 5078 - 5079
  • [40] Real-world experience of emicizumab prophylaxis in Korean children with severe hemophilia A without inhibitors
    Kim, Sung Eun
    Kim, Ji Yoon
    Park, Jeong A.
    Lyu, Chuhl Joo
    Hahn, Seung Min
    Han, Jung Woo
    Park, Young Shil
    BLOOD RESEARCH, 2024, 59 (01)
12345